Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Todd Neale

November 15, 2020

News Conference News AHA 2020

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

Todd Neale

November 15, 2020

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 362: Natural Vascular Scaffolding Therapy Shows Favorable Biocompatibility and Protection of Elastin Content in Comparison to Balloon Angioplasty and Stent in Peripheral Arteries of LDLR-Knockout Hypercholesterolemic Swine

Presenter: Greg Kaluza

October 14, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News EAS 2020

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

Michael O'Riordan

October 07, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2020

The Biggest News of 2020: TCTMD’s Top 10

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Inclisiran Approved in Europe for Lowering LDL Cholesterol

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 362: Natural Vascular Scaffolding Therapy Shows Favorable Biocompatibility and Protection of Elastin Content in Comparison to Balloon Angioplasty and Stent in Peripheral Arteries of LDLR-Knockout Hypercholesterolemic Swine

Just One-Third of European Patients Get to LDL Cholesterol Goals

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank

More Insights Into AAA Genetics Spur New Questions on Screening

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content